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Abstract
Neurological manifestations of Lyme disease (or neuroborreliosis) occur variably and while it is clear that Borrelia burgdorferi can invade
the nervous system, how it does so is not well understood. Pathogen penetration through the blood brain barrier (BBB) is often inﬂu-
enced by calcium signaling in the endothelial cells triggered by extracellular host-pathogen interactions. We examined the traversal of
B. burgdorferi across the human BBB using in vitro model systems constructed of human brain microvascular endothelial cells (HBMEC)
grown on Costar Transwell inserts. Pretreatment of the cell monolayers with BAPTA-AM (an intracellular calcium chelator) or phos-
pholipase C (PLC) inhibitor U73122 inhibited B. burgdorferi transmigration. By 5 h, BAPTA-AM signiﬁcantly inhibited (82–99%; p <0.017)
spirochete traversal of HBMEC compared to DMSO controls. Spirochete traversal was almost totally blocked (‡99%; p <0.017) after
pretreatment with the PLC-b inhibitor U73122 as a result of barrier tightening based on electric cell-substrate impedance sensing
(ECIS). The data suggest a role for calcium signaling in CNS spirochete invasion through endothelial cell barriers.
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Introduction
Lyme disease is the most frequent arthropod-borne infection
in North America and Europe [1,2]. The bacterium which is
transmitted to humans by the bites of infected Ixodes persulc-
atus complex ticks can disseminate into multiple tissues
including the peripheral and central nervous systems [1,2].
Neurological manifestations of Lyme disease (or neurobor-
reliosis) occur variably [2–4] and include meningitis, cranial
neuritis, and radiculoneuritis [4]. While it is clear that B. burg-
dorferi can invade the nervous system, how it does so is not
well understood. Using an in vitro model of the blood-brain
barrier (BBB) consisting of human brain microvascular endo-
thelial cells (HBMEC), we previously showed that host-cell
proteases [5] are required for a human neurotropic B. burg-
dorferi strain to efﬁciently cross the BBB. We now show that
host cell calcium signaling also plays an important role in this
process.
Materials and Methods
Materials
The cell membrane-permeable intracellular calcium chelator
BAPTA-AM (1,2-Bis(2-aminophenoxy)ethane-N,N,N¢,N¢-
tetraacetic acid tetrakis)acetoxymethyl ester) was obtained
from Invitrogen, and the phospholipase C (PLC) inhibitor
U-73122 (1-(6-[([17b]-3Methoxyestra-1,3,5[10]-trien-17-yl)
amino]hexyl)-1H-pyrrole-2,5-dione) was from Sigma.
The spirochetes
Low-passage (<8 in vitro passages from original isolate)
human B. burgdorferi isolates 297 (from CSF), B331, B356,
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and BL206 spirochetes [6–9] were provided courtesy Bar-
bara Johnson (CDC, Ft. Collins, CO) and Ira Schwartz (New
York Medical College, Valhalla, NY). The spirochetes were
cultured at 34C in BSK II medium containing 6% rabbit
serum [10]. Bacteria were examined for motility by dark-
ﬁeld microscopy to verify viability and that organisms were
thoroughly dispersed. Borrelia burgdorferi were quantiﬁed
using real-time PCR (qPCR) targeting the single copy chro-
mosomal ﬂgB [11]. Borrelia burgdorferi strain 297 was tested
by PCR and determined to possess both linear plasmids 25
and 28-1 [12].
The human brain microvascular endothelial cells
A HBMEC cell line whose phenotypic expression was stabi-
lized by immortalizing the cells with pSVT, a pBR322-based
plasmid containing DNA sequence encoding the SV40-large
T antigen [13] was used in these studies. Similar to the pri-
mary HBMEC cell line from which they were derived, the
transfected HBMEC express FVIII-Rag, carbonic anhydrase
IV, Ulex europus agglutinin I, take up acetylated low-density
lipoprotein, and express gamma glutamyl transpeptidase
[13,14]. HBMEC were cultured at 37C in Medium 199 (GIB-
CO) supplemented with 10% heat-inactivated fetal bovine
serum (FBS) (Invitrogen) and 1X Glutamax (GIBCO) in a
humidiﬁed environment of 95% air/5% CO2. When incubated
with the borrelia, the FBS concentration was increased to
20% to maintain spirochete viability.
Spirochete transmigration across HBMEC
HBMEC were preincubated for 30 min with 15 lM BAPTA-
AM or 5 lM U73122 in 0.5% DMSO, conditions known to
prevent subsequent seven transmembrane G-protein coupled
receptor (GPCR)-induced [Ca2+]i rise in HBMEC, then
washed three times in medium to free the HBMEC of the
inhibitors before spirochete addition [15,16]; 0.5% DMSO
alone instead of the inhibitors was used in controls. For both
BAPTA-AM and U73122-treated and untreated cultures,
based on trypan blue dye exclusion (>99% viability), [Ca2+]i
measurements [15,16], and on electric cell substrate imped-
ance sensing (ECIS) as a biosensor of cell toxicity [17], both
drugs and DMSO were found to be non-toxic to HBMEC at
concentrations used. Borrelia burgdorferi transmigration assays
were performed as described previously [5]. Endothelial cells
were seeded on collagen type I-coated 3 lm pore Transwell
inserts (Costar) and cultured until the transendothelial electri-
cal resistance (TEER) reached ‡25 X x cm2 as measure in an
EndOhm chamber and EVOM (AC voltmeter) meter (World
Precision Instruments) [5]. For 6.5 mm diameter inserts,
intact HBMEC monolayers have TEER ‡ 25 X x cm2 [5,18],
values comparable to those of epithelial cells grown on inserts
[19]. Exponential growth phase spirochetes maintained in BSK
II medium were centrifuged at 4000 g for 10 min at 4C, and
then washed twice in HBMEC medium; 2 · 105 spirochetes
were immediately added (ﬁnal volume = 200 lL) to the
HBMEC-containing inserts. The approximate MOI of Borrelia
to HBMEC was 1:1. Some inserts lacked HBMEC to establish
a baseline for B. burgdorferi transmigration (typically 5–20% of
the initial inoculum at 5 h) and viability. Cultures were incu-
bated for 5 h, spirochete motility and viability were assessed
by dark ﬁeld microscopy, and the number of spirochetes that
crossed the HBMEC and migrated into the bottom chamber
was determined by qPCR. Statistical analyses were performed
using one- or two-sided unequal variance Student’s t-tests
with p <0.05 considered signiﬁcant.
FIG. 1. Comparison of HMBEC transmigration and TEER changes in
response to Borrelia burgdorferi strains 297 (invasive) and B331 (non-
invasive). (a) 2 · 105 B. burgdorferi 297 or 331 were incubated for
5 h with HBMEC in Transwell inserts. qPCR was used to enumerate
the number of spirochetes in the inoculum and that crossed the
monolayers. The data shown are an example of three independent
experiments of triplicate determinations calculated as the number of
B. burgdorferi (±SEM) that crossed relative to B. burgdorferi 297 (p
value calculated by Student’s t-test). (b) Real-time TEER changes by
ECIS comparing B. burgdorferi strains 297 (black line) and B331 (mid-
gray line) relative to the HBMEC controls lacking spirochetes (light
gray line). The data are plotted as the mean of duplicate runs. Based
on the lower transmigration and effect of B. burgdorferi non-invasive
strain B331 on TEER, subsequent experiments focused solely on
invasive strain 297.
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Assessment of barrier function by electric cell substrate
impedance sensing
The changes in transendothelial electrical resistance (TEER)
were monitored in real-time by electric cell-substrate imped-
ance sensing (ECIS) using an ECIS Model 1600R instrument
(Applied BioPhysics, Troy, NY, USA). ECIS measures the
resistance and impedance on small gold electrodes that serve
as substrates for cell attachment and growth [20]. In our
study, HBMEC were grown on 8W10E+ ECIS arrays until
stable resistances of ‡1000 X were reached. Unlike the sin-
gle electrode 8W1E array in which HBMEC resistances are
>10 000 X, the ten-fold higher capacitance of the 8W10E+
arrays due to 20 small active electrode groups arranged in
series leads to reduced resistances (<1/10th that of the sin-
gle electrode array) while providing a more statistically rele-
vant result (ECIS 1600R instruction manual). Resistances
were recorded every 80 s for 5 h post infection, and tripli-
cate samples were averaged. Statistical analyses were per-
formed using two-sided paired Student’s t-tests with
signiﬁcance levels of p <0.05.
Results
Selecting B. burgdorferi strains for analysis
We initially screened several strains of B. burgdorferi previ-
ously documented by other investigators to cause dissemi-
nated (CSF strain 297 and BL206 from blood) or localized
(strains B331 and B356 from individual erythema migrans
skin lesions) human infections (Fig. 1, Table 1). Of these
FIG. 2. Changes in HBMEC TEER in response
to Borrelia burgdorferi are mediated by phos-
pholipase C. (a) 2 · 105 B. burgdorferi 297
were incubated for 5 h with HBMEC in Tran-
swell inserts. qPCR was used to enumerate
the number of spirochetes in the inoculum
and that crossed the monolayers. The data
shown from two independent experiments of
triplicate determinations are calculated as the
number of B. burgdorferi 297 (±SEM) that
crossed the HBMEC monolayers. * p £0.017.
DMSO was used as solvent for both U73122
and BAPTA-AM. (b) Real-time TEER changes
by ECIS also conﬁrmed that pretreatment of
HBMEC with U73122 tightens the barrier to
B. burgdorferi (gray line) relative to the DMSO
pretreated controls (back line). The data are
plotted as the Mean ± SEM (n = 3); p <0.001.
TABLE 1. Transmigration of HBMEC by different Borrelia
burgdorferi strains
B.burgdorferi
strain
(passage #)
Infection
type
Transmigration
relative to 297
t-test* References
B356 (P7) Localized 0.147 ± 0.005 p 0.043 [9]
BL206 (P5) Disseminated 1.21 ± 0.30 p 0.667 [9]
297 (P6) Disseminated 1.00 ± 0.25 [6,7]
*p Value compared to 297 determined by Student’s t-test.
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strains, HBMEC barrier transmigration varied by strain, with
297 reproducibly achieving the highest levels, and B331 and
B356, the lowest (Table 1, Fig. 1). The transmigration of
HBMEC by 297 was three- to four-fold higher than for strain
B331 (Fig. 1a), and this correlated with the ability of strain
297 to induce a three to four-fold greater reduction in TEER
by ECIS than observed for B331 (Fig. 1b). Based on the
higher degree of transmigration and greater ECIS TEER alter-
ation compared with strain B331, we selected strain 297 for
deﬁnitive investigation of the role that calcium plays in
HBMEC invasion and permeability changes.
Transmigration of B. burgdorferi across HBMEC requires
calcium signaling
We examined the hypothesis that changes in intracellular
calcium ([Ca2+]i) in HBMEC would alter B. burgdorferi 297
traversal of this endothelial barrier. As shown in Fig. 2a, by
5 h BAPTA-AM signiﬁcantly inhibited (82–99%; p <0.017)
spirochete traversal of HBMEC compared to DMSO control;
the difference in proportions of spirochetes transmigrating
between experiments 1 and 2 was not statistically different
(p >0.12). Spirochete traversal was almost totally blocked
(‡99%; p <0.017) after pretreatment with the PLC-b inhibi-
tor U73122, although there was no statistically signiﬁcant
difference in spirochete traversal when these treatments
were compared. Pretreatment of HBMEC with DMSO alone
did not signiﬁcantly alter B. burgdorferi transmigration through
endothelial cell barriers. Furthermore, spirochetes main-
tained viability/motility when assayed by darkﬁeld microscopy
whether in inserts containing either control or pretreated
HBMEC, making it unlikely that the lack of the spirochetes
crossing endothelial cell barriers was due to a direct effect
of residual chelator or antagonist. Real-time TEER changes
by ECIS also conﬁrmed that pretreatment of HBMEC with
U73122 tightened the barrier to B. burgdorferi (Fig. 2b;
p <1.51 · 10)28). These data suggest that the changes in
HBMEC [Ca2+]i induced by B. burgdorferi may be in part
mediated through extracellular signaling.
Discussion
Through direct spirochete induction of plasminogen activa-
tors and MMP expression, proteases (i.e. MMP-1, plasmin)
could compromise endothelial cell barrier integrity [5]. Cal-
cium ﬂux via PLC-b-linked GPCR activation leads to cyto-
skeletal rearrangements involved in the ability of other
pathogens to transmigrate/invade the BBB comprised of the
HMBEC we used [15,16]. Thus, we tested the ability of
B. burgdorferi to transmigrate through HBMECs by modifying
intracellular calcium levels using BAPTA and U73122
[15,16,21–23]. Both manipulations can block or reverse
decreases in TEER and/or increases in permeability in
BMEC-based models of the BBB induced by various biological
stimuli.
We now demonstrate that B. burgdorferi transmigration
across the BBB also depends on the bacterium’s ability to
inﬂuence Ca2+responses in HBMEC. Spirochete traversal of
HBMEC requires host-derived MMP-1 and plasmin [5], which
are known to stimulate the GPCR protease activated recep-
tor (PAR)-1 [24,25]. PAR-1 activation can trigger the release
of tissue-type plasminogen activator, a process known to be
inhibited by U73122 [26]. The ﬁnding that U73122 interferes
with B. burgdorferi transmigration and TEER is consistent with
a role for PARs in these processes. Other Ca2+-mediated
processes could also play a role in spirochete invasion of the
CNS where U73122 exerts its effect through inhibiting Ca2+-
entry pathways or pumps (SERCA) [27]. Our data showing
abrogation of B. burgdorferi transmigration of the BBB in the
presence of intracellular Ca2+chelators and U73122 does not
allow differentiation of these potential concepts and prompt
testing of these hypotheses.
Complete or near complete inhibition of B. burgdorferi
migration through endothelial cell barriers occurs when cal-
cium signaling pathways are interrupted. Careful examination
of this process could identify host cell mechanisms used by
the bacterium that promote dissemination as murine models
of Lyme neuroborreliosis are developed [28] and applied to
investigate other neurotropic and non-neurotropic strains.
Moreover, such studies will identify pathways amenable to
further investigation, even pharmacological prevention of dis-
seminated disease in humans using advanced agonists or
antagonists currently in clinical trials for other purposes.
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